99mTc-anti-ED-B

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name99mTc-anti-ED-B

Drug Alias Name99mTc-radiolabeled-anti-ED-B-fibronectin antibody (Bayer Schering Pharma)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionIntegrin beta-1 inhibitors

TargetsIntegrin beta-1

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBayer Schering Pharma AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBayer Schering Pharma AG

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A